Semin Neurol 2005; 25(4): 337-344
DOI: 10.1055/s-2005-923528
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Acute Stroke Treatment in the Community: Improving Our Performance and Expanding Our Options

Andrew N. Russman1 , Irene L. Katzan1 , 2
  • 1Section of Stroke and Neurocritical Care, Cleveland Clinic Foundation, Cleveland, Ohio
  • 2MetroHealth Medical Center, Cleveland, Ohio
Further Information

Publication History

Publication Date:
08 December 2005 (online)

ABSTRACT

Three-quarters of all strokes are managed outside of academic medical centers, making optimization of stroke care in the community setting a central part of minimizing the disability from stroke. In addition, the care of stroke patients crosses multiple different components of the health care system and requires a multifaceted and coordinated approach. This article reviews the current status of stroke care across the care continuum and reviews methods found to be effective in educating the public and organizing regional delivery of hyperacute stroke care. Successful community-based stroke care models and current national initiatives in improving hospital management are discussed. Local implementation of these strategies provides an exciting opportunity to improve outcomes after stroke.

REFERENCES

  • 1 Elkins J S, Johnston S C. Thirty-year projections for deaths from ischemic stroke in the United States.  Stroke. 2003;  34 2109-2112
  • 2 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group . Tissue plasminogen activator for acute ischemic stroke.  N Engl J Med. 1995;  333 1581-1587
  • 3 Katzan I L, Hammer M D, Hixson E D, Furlan A J, Abou-Chebl A, Nadzam D M. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.  Arch Neurol. 2004;  61 346-350
  • 4 Kleindorfer D, Kissela B, Schneider A et al.. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study.  Stroke. 2004;  35 e27-e29
  • 5 Arora S, Broderick J P, Frankel M Paul Coverdell Prototype Registries Writing Group et al.. Acute stroke care in the US: results from four pilot prototypes of the Paul Coverdell National Acute Stroke Registry.  Stroke. 2005;  36 1232-1240
  • 6 Cocho D, Belvis R, Marti-Fabregas J. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.  Neurology. 2005;  64 719-720
  • 7 Hacke W, Donnan G, Fieschi C et al.. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.  Lancet. 2004;  363 768-774
  • 8 Becker K, Fruin M, Gooding T, Tirschwell D, Love P, Mankowski T. Community-based education improves stroke knowledge.  Cerebrovasc Dis. 2001;  11 34-43
  • 9 Rowe A K, Frankel M R, Sanders K A. Stroke awareness among Georgia adults: epidemiology and considerations regarding measurement.  South Med J. 2001;  94 613-618
  • 10 Carroll C, Hobart J, Fox C, Teare L, Gibson J. Stroke in Devon: knowledge was good, but action was poor.  J Neurol Neurosurg Psychiatry. 2004;  75 567-571
  • 11 Pandian J D, Jaison A, Deepak S S et al.. Public awareness of warning symptoms, risk factors, and treatment of stroke in northwest India.  Stroke. 2005;  36 644-648
  • 12 Sug Yoon S, Heller R F, Levi C, Wiggers J, Fitzgerald P E. Knowledge of stroke risk factors, warning symptoms, and treatment among an Australian urban population.  Stroke. 2001;  32 1926-1930
  • 13 Schneider A T, Pancioli A M, Khoury J C et al.. Trends in community knowledge of the warning signs and risk factors for stroke.  JAMA. 2003;  289 343-346
  • 14 Silver F L, Rubini F, Black D, Hodgson C S. Advertising strategies to increase public knowledge of the warning signs of stroke.  Stroke. 2003;  34 1965-1968
  • 15 Maze L M, Bakas T. Factors associated with hospital arrival time for stroke patients.  J Neurosci Nurs. 2004;  36 136-141, 155
  • 16 Schroeder E B, Rosamond W D, Morris D L, Evenson K R, Hinn A R. Determinants of use of emergency medical services in a population with stroke symptoms: the Second Delay in Accessing Stroke Healthcare (DASH II) Study.  Stroke. 2000;  31 2591-2596
  • 17 Katzan I L, Graber T M, Furlan A J et al.. Cuyahoga County Operation Stroke speed of emergency department evaluation and compliance with National Institutes of Neurological Disorders and Stroke time targets.  Stroke. 2003;  34 994-998
  • 18 Morris D L, Rosamond W, Madden K, Schultz C, Hamilton S. Prehospital and emergency department delays after acute stroke: the Genentech Stroke Presentation Survey.  Stroke. 2000;  31 2585-2590
  • 19 Silliman S L, Quinn B, Huggett V, Merino J G. Use of a field-to-stroke center helicopter transport program to extend thrombolytic therapy to rural residents.  Stroke. 2003;  34 729-733
  • 20 Kothari R U, Pancioli A, Liu T, Brott T, Broderick J. Cincinnati Prehospital Stroke Scale: reproducibility and validity.  Ann Emerg Med. 1999;  33 373-378
  • 21 Nor A M, McAllister C, Louw S J et al.. Agreement between ambulance paramedic- and physician-recorded neurological signs with Face Arm Speech Test (FAST) in acute stroke patients.  Stroke. 2004;  35 1355-1359
  • 22 Kidwell C S, Starkman S, Eckstein M, Weems K, Saver J L. Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS).  Stroke. 2000;  31 71-76
  • 23 Llanes J N, Kidwell C S, Starkman S, Leary M C, Eckstein M, Saver J L. The Los Angeles Motor Scale (LAMS): a new measure to characterize stroke severity in the field.  Prehosp Emerg Care. 2004;  8 46-50
  • 24 Crocco T, Gullett T, Davis S M et al.. Feasibility of neuroprotective agent administration by prehospital personnel in an urban setting.  Stroke. 2003;  34 1918-1922
  • 25 Saver J L, Kidwell C, Eckstein M, Starkman S. Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial.  Stroke. 2004;  35 e106-e108
  • 26 Marler JR, Jones PW, Emr M Rapid Identification and Treatment of Acute Stroke: Proceedings of a National Symposium. Bethesa, MD; National Institutes of Health 1997
  • 27 Instructions and Forms for Primary Stroke Service Designation Application .Available at: http://www.mass.gov/dph/dhcq/stroke_app.htm Accessed March 18, 2005
  • 28 Reed S D, Cramer S C, Blough D K, Meyer K, Jarvik J G. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals.  Stroke. 2001;  32 1832-1840
  • 29 Ruland S, Gorelick P B, Schneck M, Kim D, Moore C G, Leurgans S. Acute stroke care in Illinois: a statewide assessment of diagnostic and treatment capabilities.  Stroke. 2002;  33 1334-1339
  • 30 Camilo O, Goldstein L B. Statewide assessment of hospital-based stroke prevention and treatment services in North Carolina: changes over the last 5 years.  Stroke. 2003;  34 2945-2950
  • 31 Burgin W S, Staub L, Chan W et al.. Acute stroke care in non-urban emergency departments.  Neurology. 2001;  57 2006-2012
  • 32 Morgenstern L B, Staub L, Chan W et al.. Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project.  Stroke. 2002;  33 160-166
  • 33 Morgenstern L B, Bartholomew L K, Grotta J C, Staub L, King M, Chan W. Sustained benefit of a community and professional intervention to increase acute stroke therapy.  Arch Intern Med. 2003;  163 2198-2202
  • 34 Frey J L, Jahnke H K, Goslar P W, Partovi S, Flaster M S. tPA by telephone: extending the benefits of a comprehensive stroke center.  Neurology. 2005;  64 154-156
  • 35 Merino J G, Silver B, Wong E et al.. Extending tissue plasminogen activator use to community and rural stroke patients.  Stroke. 2002;  33 141-146
  • 36 Wang D Z, Rose J A, Honings D S, Garwacki D J, Milbrandt J C. Treating acute stroke patients with intravenous tPA: the OSF stroke network experience.  Stroke. 2000;  31 77-81
  • 37 Grotta J C, Burgin W S, El Mitwalli A et al.. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000.  Arch Neurol. 2001;  58 2009-2013
  • 38 Audebert H J, Kukla C, Clarmann V C et al.. Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria.  Stroke. 2005;  36 287-291
  • 39 Handschu R, Littmann R, Reulbach U et al.. Telemedicine in emergency evaluation of acute stroke: interrater agreement in remote video examination with a novel multimedia system.  Stroke. 2003;  34 2842-2846
  • 40 Wang S, Gross H, Lee S B et al.. Remote evaluation of acute ischemic stroke in rural community hospitals in Georgia.  Stroke. 2004;  35 1763-1768
  • 41 Meyer B C. The “Stroke Team Remote Evaluation Using a Digital Observation Camera (STRokE DOC)” Telemedicine System: methods.  Stroke. 2005;  36 494 , (Abstract)
  • 42 LaMonte M P. A comprehensive telemedicine program for stroke: The University of Maryland experience.  Neurology. 2005;  64(suppl 1) A272 , (Abstract)
  • 43 ACEP agrees with reservations to new stroke guidelines.  ACEP New. 1996;  3 15
  • 44 Brott T. Thrombolysis for stroke.  Arch Neurol. 1996;  53 1305-1306
  • 45 Katzan I L, Sila C A, Furlan A J. Community use of intravenous tissue plasminogen activator for acute stroke: results of the brain matters stroke management survey.  Stroke. 2001;  32 861-865
  • 46 Bravata D M, Kim N, Concato J, Krumholz H M, Brass L M. Thrombolysis for acute stroke in routine clinical practice.  Arch Intern Med. 2002;  162 1994-2001
  • 47 Katzan I L, Furlan A J, Lloyd L E et al.. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience.  JAMA. 2000;  283 1151-1158
  • 48 Hill M D. The Canadian Activase for Stroke Effectiveness Study (CASES): final results.  Stroke. 2002;  33 359 , (Abstract)
  • 49 Katzan I L, Hammer M D, Furlan A J, Hixson E D, Nadzam D M. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update.  Stroke. 2003;  34 799-800
  • 50 Kleindorfer D, Hill M D, Woo D et al.. A description of Canadian and United States physician reimbursement for thrombolytic therapy administration in acute ischemic stroke.  Stroke. 2005;  36 682-687
  • 51 Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 2006 Rates. 42CFR Parts 205, 412, 415, 419, and 485. Centers for Medicare and Medicaid Services, Department of Health and Human Services, CMS-1500-F 2005
  • 52 Adams Jr H P, Brott T G, Crowell R M et al.. Guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.  Circulation. 1994;  90 1588-1601
  • 53 Langhorne P, Dennis M. Stroke Units: An Evidence Based Approach. London; BMJ Books 1998
  • 54 Jorgensen H S, Kammersgaard L P, Houth J et al.. Who benefits from treatment and rehabilitation in a stroke unit? A community-based study.  Stroke. 2000;  31 434-439
  • 55 Stroke Unit Trialists' Collaboration . Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke.  BMJ. 1997;  314 1151-1159
  • 56 Johnston K C, Li J Y, Lyden P D et al.. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators.  Stroke. 1998;  29 447-453
  • 57 Katzan I L, Cebul R D, Husak S H, Dawson N V, Baker D W. The effect of pneumonia on mortality among patients hospitalized for acute stroke.  Neurology. 2003;  60 620-625
  • 58 Evans A, Perez I, Harraf F et al.. Can differences in management processes explain different outcomes between stroke unit and stroke-team care?.  Lancet. 2001;  358 1586-1592
  • 59 Alberts M J, Hademenos G, Latchaw R E et al.. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition.  JAMA. 2000;  283 3102-3109
  • 60 Kidwell C S, Shephard T, Tonn S et al.. Establishment of primary stroke centers: a survey of physician attitudes and hospital resources.  Neurology. 2003;  60 1452-1456
  • 61 Alberts M J, Latchaw R E, Selman W R et al.. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition.  Stroke. 2005;  36 1597-1616
  • 62 Dion J E. Management of ischemic stroke in the next decade: stroke centers of excellence.  J Vasc Interv Radiol. 2004;  15 S133-S141
  • 63 Schwamm L H. Get with the guidelines stroke: baseline data on secondary prevention.  Stroke. 2003;  34 288 , (Abstract)
  • 64 LaBresh K A. Does “get with the guidelines” improve secondary prevention in patients hospitalized with acute stroke or TIA?.  Stroke. 2005;  36 454 , (Abstract)
  • 65 Schwamm L H. “Get with the guidelines” improves acute intervention in patients hospitalized with ischemic stroke or TIA.  Stroke. 2005;  36 436 , (Abstract)

Irene KatzanM.D. M.S. 

Assistant Professor of Neurology, Case Western Reserve University, Section of Stroke and Neurocritical Care, Cleveland Clinic Foundation

9500 Euclid Avenue, S91, Cleveland, OH 44195

    >